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Abstract Primary angle closure occurs as a result of
crowded anterior segment anatomy, causing apposi-
tional contact between the peripheral iris and trabec-
ular meshwork, thereby obstructing aqueous outflow.
Several studies highlight the role of the crystalline lens
in its pathogenesis. The objective of this work is to
compare the long-term efficacy of phacoemulsifica-
tion versus laser peripheral iridotomy (LPI) in the
management of chronic primary angle closure
(CPAC). Prospective case–control study with 30 eyes
of 30 patients randomly divided in two groups: 15 eyes
in the LPI group and 15 eyes in the IOL group. Patients
in the LPI group underwent LPI using argon and
Nd:YAG laser. Patients in the IOL group underwent
phacoemulsification with posterior chamber intraocu-
lar lens (IOL) implantation. Examinations before and
after the procedure included gonioscopy, Goldmann
applanation tonometry, and anterior chamber evalua-
tion using the Pentacam rotating Scheimpflug camera.
The mean follow-up time was 31.13 ± 4.97 months.
There was a statistically significant reduction in the
intraocular pressure (IOP) and number of anti-glau-
coma medications (p \ 0.01) only in the IOL group.
Anterior chamber depth, angle, and volume were all
higher in the IOL group (p \ 0.01) at the end of the
follow-up period. Phacoemulsification with posterior
chamber IOL implantation results in a higher anterior
chamber depth, angle, and volume, when compared to
LPI. Consequently, phacoemulsification has greater
efficacy in lowering IOP and preventing its long-term
increase in patients with CPAC and cataract.
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Introduction
Primary angle closure (PAC) occurs as a result of
crowded anterior segment anatomy, causing apposi-
tional contact between the peripheral iris and trabecular
meshwork, thereby obstructing aqueous outflow [1]. By
the time this blockage causes pressure-induced optic
neuropathy, the condition is called primary angle closure
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glaucoma (PACG). PACG accounts for half of all
glaucoma blindness worldwide [2]. PACG or PAC and
cataract often coexist and the crystalline lens plays a
pivotal role in their pathogenesis. The cardinal anatomic
characteristic in eyes with angle closure is a thicker,
more anteriorly positioned crystalline lens in compari-
son to unaffected eyes. Thickening and forward move-
ment of the lens occur with aging, which explains why
PACG is more commonly found in older patients [3].
Laser peripheral iridotomy (LPI) has been used
widely for treating acute or chronic angle closure by
relieving pupillary block, by far the most common
cause of PAC. However, despite being very effective in
preventing symptomatic acute pressure rises in PAC
patients who have had one episode in their fellow eye
[4, 5], it is not completely effective in preventing long-
term asymptomatic rises in intraocular pressure (IOP)
[5]. Angle width increases in most eyes after LPI, but
between 20 and 25 % of eyes, show no change [6, 7].
Several studies have demonstrated the efficacy of
cataract surgery in chronic angle closure glaucoma [8,
9], as well as in controlling IOP after an episode of acute
angle closure glaucoma [10, 11]. The objective of this
study is to compare the long-term results of phacoe-
mulsification with posterior chamber intraocular lens
(IOL) implantation versus LPI in the management of
chronic primary angle closure with cataract, in terms of
clinical efficacy and anterior chamber parameters.
Methods
This study was conducted at Central Lisbon Hospital
Center, a university-based tertiary center. Patients were
prospectively recruited between January and June 2010.
Written, informed consent was obtained from all
subjects and this investigation adhered to the tenets of
the Declaration of Helsinki. Ethics Committee approval
was obtained. Patients with cataract and PAC or
controlled PACG, without history of intraocular surgery
or any other ocular disease were included in this study.
Diagnosis of PAC was made when gonioscopy
revealed two or more quadrants of irido-trabecular
contact with gaze in the primary position and another
abnormality: either IOP [21 mmHg or peripheral
anterior synechiae extending across the scleral spur,
without iritis or any other signs of ocular pathology
other than cataract [12]. Additionally, the presence of
glaucomatous optic disk excavation, reproducible
visual field abnormality or both leaded to the diagnosis
of chronic PACG.
Thirty eyes of 30 patients included in the study were
randomly divided in two groups: 15 eyes underwent
LPI—LPI group—and 15 eyes underwent phacoemul-
sification with posterior chamber IOL implantation—
IOL group. Patient randomization was performed
using a computer-based randomization program
(www.randomization.com—accessed on 15th Janu-
ary 2010).
Phacoemulsification with IOL implantation was
performed by two surgeons (JPC and JPS). Preoper-
ative intravenous manitol 20 % at 1–2 g/kg was given
2 h before surgery for all patients. Under topical
anesthesia, a 2.75 mm clear cornea incision was made.
After continuous curvilinear capsulorhexis, standard
phacoemulsification was performed using the ‘‘phaco-
chop’’ technique. A posterior chamber foldable IOL
with a 6.0 mm acrylic optic (Acrysof IQ, Alcon, Fort
Worth, TX) was implanted in the capsular bag. At the
end of the surgery, intracameral cefuroxime was
injected. Postoperative treatment included topical
steroids and antibiotics, tapered over 1 month.
Laser peripheral iridotomy was performed under
topical anesthesia, using combined argon and Nd:YAG
laser. It was sited at the superior nasal or superior
temporal quadrant and the size of the opening was
C200 lm. One drop of apraclonidine 1 % was admin-
istered 1 h before the procedure. Postoperative treat-
ment included 1 drop of apraclonidine 1 % immediately
after the procedure and topical steroids for 1 week.
Supplementary laser iridotomy was performed when
needed (small or closed iridotomy).
Visual acuity (VA), number of anti-glaucoma
medications, gonioscopy, and IOP (Goldmann appla-
nation tonometry was used, with three readings taken
and the mean value recorded) were assessed in both
groups. Morphologic examination of the anterior
chamber using the Pentacam Scheimpflug camera
(Pentacam HR, Oculus, Germany) was also performed
and the following parameters were analyzed: anterior
chamber depth (ACD), anterior chamber angle (ACA),
and anterior chamber volume (ACV).
The data were statistically analyzed using SPSS for
Windows, version 20.0; IBM/SPSS, Chicago, IL.
Student’s t test was performed and a p value of less
than 0.01 was deemed statistically significant. All the
results were expressed as mean ± standard deviation,
with ranges between brackets.
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Results
Thirty patients were enrolled in the study: 15 in the
LPI group, 3 men and 12 women; and 15 in the IOL
group, 4 men and 11 women. The mean age in the LPI
group was 65.10 ± 9.49 (44–76) years and the mean
age in the IOL group was 69.5 ± 11.34 (52–86) years
(p = 0.180). Preoperative clinical and ocular data are
shown in Table 1. There was a statistically significant
difference only in the number of preoperative drugs,
which was higher in the IOL group.
The mean follow-up time was 31.13 ± 4.97 months.
The postoperative clinical and ocular data for both
groups are shown in Table 2. There were statistically
significant differences for all the anterior chamber
parameters determined with the Pentacam, which were
higher in the IOL group, but not for IOP, number of
anti-glaucoma drugs or BCVA. 93.3 % (14 eyes in 15)
of the eyes in the LPI group maintained two or more
quadrants of iridocorneal contact on gonioscopy,
while none of the eyes in the IOL group presented
two or more quadrants of iridocorneal contact after the
follow-up period.
Tables 3 and 4 compare the pre and postoperative
data for LPI and IOL groups, respectively. There were
no statistically significant differences between pre and
postoperative IOP, number of anti-glaucoma medica-
tions, BCVA or anterior chamber parameters in the
LPI group. In the IOL group, the IOP and number of
anti-glaucoma medications were significantly lower
and all the anterior chamber parameters were higher
after the follow-up period (p \ 0.01).
There were no complications during or after any of
the surgical procedures, and there were no cases of
acute angle closure in any of the eyes enrolled in the
study during the whole follow-up.
Discussion
The results of this study suggest that phacoemulsifi-
cation with posterior chamber IOL implantation
significantly reduced IOP and the number of anti-
glaucoma medications after a long-term follow-up. On
the other hand, LPI did not significantly decrease the
IOP or the number of anti-glaucoma medications.
Table 1 Preoperative intraocular pressure (IOP), number of anti-glaucoma drugs, best corrected visual acuity (BCVA), anterior
chamber depth (ACD), anterior chamber volume (ACV), and anterior chamber angle (ACA)
LPI group IOL group p value
IOP (mm Hg) 15.07 ± 3.26 (10–22) 19.93 ± 8.30 (10–46) 0.022
No. drugs 0.6 ± 1.12 (0–3) 1.67 ± 1.18 (0–3) 0.008*
BCVA 0.88 ± 0.18 (0.5–0.9) 0.64 ± 0.34 (0.2–0.9) 0.010
ACD (mm) 2.02 ± 0.29 (1.52–2.42) 1.82 ± 0.33 (1.07–2.23) 0.045
ACV (mm3) 88.27 ± 21.72 (47–112) 77.60 ± 17.96 (39–100) 0.077
ACA (degrees) 22.40 ± 4.39 (17.1–30.1) 24.85 ± 6.42 (9.0–33.2) 0.116
* Statistically significant difference between both groups
Table 2 Postoperative intraocular pressure (IOP), number of anti-glaucoma drugs, best corrected visual acuity (BCVA), anterior
chamber depth (ACD), anterior chamber volume (ACV), and anterior chamber angle (ACA)
LPI group IOL group p value
IOP (mm Hg) 14.87 ± 2.19 (10–18) 14.53 ± 1.51 (11–17) 0.316
No. drugs 0.40 ± 0.83 (0–3) 0.93 ± 0.59 (0–2) 0.026
BCVA 0.75 ± 0.31 (0.1–0.9) 0.87 ± 0.21 (0.2–1.0) 0.280
ACD (mm) 1.99 ± 0.27 (1.57–2.45) 3.87 ± 0.48 (3.36–5.04) \0.001*
ACV (mm3) 102.47 ± 19.15 (68–135) 159.67 ± 23.01 (125–196) \0.001*
ACA (degrees) 23.05 ± 3.06 (19.0–29.9) 43.98 ± 8.71 (30.9–56.2) \0.001*
* Statistically significant difference between both groups
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Analyzing the preoperative clinical data of both
groups, one can see that the number of anti-glaucoma
medications was significantly higher in the phacoe-
mulsification group. The preoperative IOP values
were also higher (although not statistically significant)
in the IOL group. This was probably the result of the
limited sample size and explains why we didn’t obtain
statistically significant differences in these variables
between the two groups after the follow-up. However,
comparing preoperative and postoperative values,
there are statistically significant differences only in
the IOL group. Regarding the anterior chamber
parameters, there were significant increments in the
ACD, volume, and angle in the IOL group, but not in
the LPI group. This is probably related to the
pathophysiological mechanisms that increase the
aqueous drainage after cataract surgery in these
patients. Removal of the lens can deepen the anterior
chamber and relieve the crowding of the angle [13,
14]. The stretching effect of the IOL in the bag could
also open spaces in the trabecular meshwork that can
explain the long-term decrease in the IOP [15].
Moreover Shams et al. [16] identified a significant
reduction in peripheral anterior synechiae following
cataract extraction alone, even without goniosynechi-
alysis. Another possible mechanism that has been
proposed to explain the improved aqueous outflow
facility is the increase in prostaglandin release [15,
17]. The cytokine modulation triggered by the effect
of ultrasound in the trabecular meshwork could also
motivate an increase in its permeability [18]. In fact,
the narrower the anterior chamber, the greater increase
in the anterior chamber parameters and the higher
effect in IOP after cataract surgery [19–21].
Other studies had already demonstrated the
improvement in anterior chamber parameters after
cataract surgery [22–26] but this, to our knowledge,
has the longest follow-up, demonstrating the stability
of these changes, as well as their effect in IOP control.
Laser peripheral iridotomy, which acts by relieving
pupillary block, has been advocated as the initial
treatment in eyes with PACG because of its noninva-
sive nature and safety [27]. However, despite its
efficacy in preventing acute angle closure attacks, its
effect in long-term control of IOP in eyes with chronic
primary angle closure is more debatable [5]. The
probable explanation for this fact is that a considerable
number of patients have a mixed mechanism for angle
Table 3 Pre and postoperative intraocular pressure (IOP), number of anti-glaucoma drugs, best corrected visual acuity (BCVA),
anterior chamber depth (ACD), anterior chamber volume (ACV), and anterior chamber angle (ACA) for patients in the LPI group
Before LPI After LPI p value
IOP (mm Hg) 15.07 ± 3.26 (10–22) 14.87 ± 2.19 (10–18) 0.423
No. drugs 0.6 ± 1.12 (0–3) 0.40 ± 0.83 (0–3) 0.291
BCVA 0.88 ± 0.18 (0.5–0.9) 0.75 ± 0.31 (0.1–0.9) 0.064
ACD (mm) 2.02 ± 0.29 (1.52–2.42) 1.99 ± 0.27 (1.57–2.45) 0.416
ACV (mm3) 88.27 ± 21.72 (47–112) 102.47 ± 19.15 (68–135) 0.034
ACA (degrees) 22.40 ± 4.39 (17.1–30.1) 23.05 ± 3.06 (19.0–29.9) 0.322
Table 4 Pre and postoperative intraocular pressure (IOP), number of anti-glaucoma drugs, best corrected visual acuity (BCVA),
anterior chamber depth (ACD), anterior chamber volume (ACV), and anterior chamber angle (ACA) for patients in the IOL group
Before IOL After IOL p value
IOP (mm Hg) 19.93 ± 8.30 (10–46) 14.53 ± 1.51 (11–17) 0.009*
No. drugs 1.67 ± 1.18 (0–3) 0.93 ± 0.59 (0–2) 0.003*
BCVA 0.64 ± 0.34 (0.2–0.9) 0.87 ± 0.21 (0.2–1.0) 0.015
ACD (mm) 1.82 ± 0.33 (1.07–2.23) 3.87 ± 0.48 (3.36–5.04) \0.001*
ACV (mm3) 77.60 ± 17.96 (39–100) 159.67 ± 23.01 (125–196) \0.001*
ACA (degrees) 24.85 ± 6.42 (9.0–33.2) 43.98 ± 8.71 (30.9–56.2) \0.001*
* Statistically significant difference
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closure [28, 29]. On the other hand, cataract surgery
relieves angle closure by attenuating various causative
factors like pupillary block, plateau iris, and lens-
associated [13, 30]. Hata et al. [31] compared the
efficacy of LPI versus phacoemulsification for the
management of chronic angle closure, after 6 months
follow-up. Patients who underwent cataract surgery
presented a 2.8 mmHg additional reduction in IOP
with similar corneal endothelial cell counts as com-
pared to patients who underwent LPI alone. Nonaka
et al. [23] reported that cataract surgery subsequent to
laser iridotomy was also effective for complete
resolution of residual angle closure, with concomitant
control of IOP. Therefore, LPI with subsequent
cataract surgery is also a feasible strategy to manage
chronic angle closure. However, one must keep in
mind that, although the risk is low, laser iridotomy
may pose a hazard to the corneal endothelium which is
cumulative with the endothelial damage during
subsequent phacoemulsification. Moreover, LPI also
increases the risk of cataract, making a future cataract
surgery more probable. Thus, phacoemulsification
with posterior chamber IOL implantation is, in our
opinion, becoming a first line therapy for eyes with
PAC and cataract. Regarding the role of clear lens
extraction in the management of PAC, only a few
papers have addressed this matter [8, 32]. The EAGLE
study, which is due to report in 2014, will compare
clinical outcomes and cost-effectiveness of clear lens
extraction in PACG patients with standard care [33].
The authors acknowledge some limitations to this
study. The limited sample size has led to some
differences in the two study groups, which, however,
did not compromise the main outcomes of this work.
Nevertheless, and in order to try to compensate for this
sample size limitation—and the appearance of what
could have been false positive statistically significant
results—we have decreased the p value (from standard
0.05 to 0.01) needed for statistical significance.
Second, the Pentacam is not a very precise exam to
measure ACA, however, it gives precise and repro-
ducible measures of ACV and depth [34]. Moreover,
PAS evaluation by gonioscopy was made only qual-
itatively. Pre and postoperative assessment of PAS
index, location, height, and width would have been
important to better understand the long-term effect of
the two different strategies on this important variable
[35]. Finally, phacoemulsification in these eyes may
sometimes be a complex procedure. In this study, they
were performed by two experienced surgeons, there-
fore, the results may not be generalizable to the less
experienced.
In conclusion, this study, which has the longest
follow-up, proved that phacoemulsification with pos-
terior chamber IOL implantation is a safe and more
effective procedure than LPI in lowering IOP and
preventing its long-term increase. This success is
achieved by improving anterior chamber morphology
in patients with chronic PAC and cataract.
Conflict of interest No conflicting relationship exists for any
author.
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